A study examining isolated human ureteral smooth muscle suggested that cAMP, and not cGMP, plays the predominant role in the reduction of potassium chloride‐induced tone of isolated ureteral smooth muscle, suggesting the potential therapeutic use of PDE‐4 inhibitors for the treatment of ureteral stones and ureteral colic.26 The gene discussed is PDE4A; the disease is ureterolithiasis.